SA
Go ProLog In
ARDT
OverviewIntelligenceChart

Analyst Sentiment

Wall St. Consensus
Buy
11 analysts·Moderate coverage
66
Score
8 Buy (73%)2 Hold (18%)1 Sell (9%)
Rating Breakdown
Strong Buy
00%
Buy
873%
Hold
218%
Sell
19%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$12.00
+18.8%
Consensus
$13.00
+28.7%
Bull
$14.00
+38.6%
12-Month Target Range11 analysts
$12.00$13.00$14.00
Current $10.10Consensus
Current Price
$10.10
Upside to Consensus
$2.90

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+4.39%
EPS+14.44%
FY2028
Rev+5.09%
EPS+5.06%

Earnings Surprises

Recent Analyst Actions

Mar 9, 2026RBC Capital
Ardent Health Partners Inc (ARDT) PT Lowered to $13 at RBC Capital
Target:$13.00
+41.8%from $9.17
Dec 18, 2025UBS
Ardent Health price target lowered to $14 from $14.50 at UBS
Target:$14.00
+56.7%from $8.94
Dec 18, 2025Mizuho Securities
Ardent Health price target lowered to $12 from $20 at Mizuho
Target:$12.00
+34.2%from $8.94
Nov 18, 2025Mizuho Securities
Ardent Health price target lowered to $13 from $20 at Mizuho
Target:$13.00
+49.4%from $8.70
Nov 14, 2025Leerink Partners
Ardent Health price target lowered to $16 from $23 at Leerink
Target:$16.00
+77.6%from $9.01
Nov 14, 2025Truist Financial
Ardent Health price target lowered to $13 from $21 at Truist
Target:$13.00
+45.7%from $8.92
Nov 14, 2025RBC Capital
Ardent Health Partners Inc (ARDT) PT Lowered at RBC Capital Amid Near-Term Headwind
Target:$16.00
+78.4%from $8.97
Nov 14, 2025Morgan Stanley
Ardent Health downgraded to Equal Weight from Overweight at Morgan Stanley
Target:$12.00
+29.0%from $9.30
Oct 14, 2025Goldman Sachs
Ardent Health initiated with a Neutral at Goldman Sachs
Target:$19.00
+34.5%from $14.13
Sep 10, 2025UBS
Ardent Health initiated with a Buy at UBS
Target:$17.00
+30.5%from $13.03
Mar 4, 2025RBC Capital
Ardent Health price target lowered to $21 from $23 at RBC Capital
Target:$21.00
+39.7%from $15.03
Oct 10, 2024KeyBanc
Ardent Health initiated with an Overweight at KeyBanc
Target:$24.00
+32.5%from $18.12
Sep 19, 2024Stephens
Stephens Reiterates Overweight Rating on Ardent Health Partners Inc (ARDT)
Target:$24.00
+39.5%from $17.21
Aug 16, 2024Loop Capital Markets
Ardent Health price target raised to $21 from $18 at Loop Capital
Target:$21.00
+23.7%from $16.97
Aug 16, 2024Truist Financial
Ardent Health price target raised to $22 from $21 at Truist
Target:$22.00
+29.6%from $16.97
Aug 12, 2024Truist Financial
Ardent Health initiated with a Buy at Truist
Target:$21.00
+34.3%from $15.64
Aug 12, 2024Mizuho Securities
Ardent Health initiated with an Outperform at Mizuho
Target:$20.00
+27.9%from $15.64
Aug 12, 2024Morgan Stanley
Ardent Health initiated with an Overweight at Morgan Stanley
Target:$27.00
+72.6%from $15.64

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance